CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market sale 10% owner sold 44,417 shares at $4.20 ($186,600)
- 4 Open-market buy CEO, Chairman of the Board bought 5,000 shares at $4.22 ($21,095)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 452,587 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 146,862 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 355,282 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Shares withheld for taxes Director gave up 24,618 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 24,618 shares (to pay taxes)
- 4 Other acquisition Chief Financial Officer acquired 5,228 shares (other)
- 4 Other acquisition Chief Operating Officer acquired 4,357 shares (other)
- 4 Option exercise Director acquired 32,811 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 60,280 shares (to pay taxes)
Page 14 of 30 · 591 filings